COMPLETEDPHASE4

Evaluation of Reader Training Processes

Evaluation of Reader Training Processes by Comparing Clinical Interpretations to Centralized Expert Reads

NCT02051790•Avid Radiopharmaceuticals

Summary

This study is designed to evaluate the agreement between florbetapir F 18 scan interpretation in the clinic and by expert readers.

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•\- Scan obtained for clinical reasons

Exclusion Criteria

•\- None

Locations (1)

Research Site

Philadelphia, Pennsylvania, United States

Key Dates

Start Date

March 1, 2014

Primary Completion Date

August 1, 2014

Completion Date

August 1, 2014

Last Updated

September 28, 2015

Enrollment

241

ACTUAL participants

Conditions

Alzheimer's Disease

Interventions

florbetapir F 18

DRUG

ACP-204 in Adults With Alzheimer's Disease Psychosis

NCT06159673

Alzheimer's Disease Psychosis

View study

RECRUITING

Lombard Cohort of Brain Health Services

NCT07457138

Subjective Cognitive Decline (SCD)Functional Cognitive Disorder+2 more

View study

RECRUITING

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 28, 2015Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

PHASE2